Research Studies
Back to Results
ODYSSEY: A randomized, double-blind, placebo-controlled study to investigate the efficacy of tradipitant in treating inflammatory lung injury and improving clinical outcomes associated with severe COVID-19 infection
Description
The tradipitant therapy is being studied to explore if the administration prevents or treats the cytokine storm and acute respiratory distress syndrome leading to respiratory failure and high mortality in affected patients with COVID-19.
Details
Age
Adult
Eligibility
Adults aged 18-90 with confirmed laboratory COVID-19 infection and hospitalized for treatment.
Detailed Eligibility: Patients participating in other clinical trials are excluded
Phase
III - Research Studies that gather more information about a drug's safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs. These studies typically involve more participants.
Type of Study
Treatment
Scope
National
Locations
Memorial Hospital Central
Memorial Hospital North
Principal Investigator
Ronald Rains
Study ID
Protocol Number: 20-6506
ClinicalTrials.gov: NCT04326426
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers